REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 63 filers reported holding REPARE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,994,922 | +13.5% | 3,016,674 | +0.6% | 14.27% | +48.2% |
| Q2 2023 | $31,726,606 | +7.5% | 2,998,734 | +0.0% | 9.63% | +22.9% |
| Q1 2023 | $29,499,719 | -28.4% | 2,997,939 | +7.1% | 7.83% | -28.6% |
| Q4 2022 | $41,189,854 | +10.6% | 2,800,126 | -8.8% | 10.97% | +9.6% |
| Q3 2022 | $37,237,000 | +0.6% | 3,069,847 | +16.0% | 10.01% | -29.2% |
| Q2 2022 | $37,028,000 | +0.7% | 2,646,781 | +2.5% | 14.14% | -9.5% |
| Q1 2022 | $36,755,000 | -21.2% | 2,581,097 | +16.7% | 15.63% | +0.9% |
| Q4 2021 | $46,656,000 | -20.4% | 2,212,256 | -0.9% | 15.49% | -9.4% |
| Q3 2021 | $58,588,000 | -26.0% | 2,232,783 | -12.1% | 17.10% | -7.2% |
| Q2 2021 | $79,186,000 | +0.8% | 2,539,644 | -0.8% | 18.42% | +17.1% |
| Q1 2021 | $78,588,000 | -9.5% | 2,560,703 | +1.1% | 15.73% | -35.7% |
| Q4 2020 | $86,853,000 | +11.5% | 2,532,150 | +0.1% | 24.47% | -11.7% |
| Q3 2020 | $77,863,000 | +0.3% | 2,530,494 | +1.1% | 27.70% | -8.6% |
| Q2 2020 | $77,656,000 | – | 2,503,408 | – | 30.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,242,636 | $22,067,538 | 9.20% |
| CHI Advisors LLC | 2,997,939 | $29,499,719 | 7.83% |
| MPM BioImpact LLC | 1,639,849 | $16,136,114 | 4.19% |
| BVF INC/IL | 8,291,988 | $81,593,162 | 2.98% |
| HighVista Strategies LLC | 164,890 | $1,622,518 | 1.32% |
| Sio Capital Management, LLC | 228,538 | $2,248,814 | 1.11% |
| Deep Track Capital, LP | 2,727,606 | $26,839,643 | 1.10% |
| Redmile Group, LLC | 2,533,050 | $24,925,212 | 1.08% |
| Orbimed Advisors | 3,322,488 | $32,693,282 | 0.64% |
| Artal Group S.A. | 700,000 | $6,888 | 0.41% |